The present invention relates to a method for inhibiting telomerase in cancer cells by means of luterion and, more particularly, to a method for inhibiting telomerase activity in cancer tissues, cancer cells or a cancer patient, the method in which administered are: an anti-cancer composition containing luterion a composition for inhibiting telomerase activity in cancer cells and luterion. Luterion, according to the present invention, has the advantage of effectively inhibiting only the proliferation of cancer cells, without affecting normal cells, by inhibiting telomerase activity in cancer cells.La présente invention concerne un procédé dinhibition de la télomérase dans des cellules cancéreuses au moyen de luterion et, plus particulièrement, un procédé dinhibition de lactivité de la télomérase dans des tissus cancéreux, des cellules cancéreuses ou un patient atteint dun cancer. Les éléments suivants sont administrés dans ledit procédé : une composition anti-cancer contenant du luterion une composition pour inhiber lactivité de la télomérase dans des cellules cancéreuses et du luterion. Le luterion, selon la présente invention, présente lavantage dinhiber efficacement la prolifération des cellules cancéreuses uniquement, sans affecter les cellules normales, par linhibition de lactivité de la télomérase dans des cellules cancéreuses.본 발명은 루테리온을 이용한 암세포의 텔로머라아제 억제방법에 관한 것으로, 더욱 자세하게는 루테리온을 함유하는 항암 조성물 암세포의 텔로머라아제 활성 억제용 조성물 및 루테리온을 투여하는 것을 특징으로 하는 암 조직, 암 세포 또는 암환자의 텔로머라아제 활성 억제방법에 관한 것이다. 본 발명에 따르면, 루테리온은 암세포에서 텔로머라아제 활성을 저해하여, 정상세포에 영향 없이 효과적으로 암세포의 증식만을 억제시키는 효과가 있다.
